DOI:
10.1055/s-00034612
Yearbook of Medical Informatics
LinksClose Window
References
Matulonis UA, Penson RT, Domchek SM, Kaufman B, Shapira-Frommer R, Audeh MW. , et al.
Olaparib monotherapy in patients with advanced relapsed ovarian cancer and a germline BRCA1/2 mutation: a multistudy analysis of response rates and safety.
Ann Oncol 2016;
27 (06) 1013-9
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.